The role of artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis

Ziqi Zhao, Kun Xu, Yizhuo Jiang, Xisheng Xu, Yuliang Liu · 2024

Read The role of artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis by Ziqi Zhao, Kun Xu, Yizhuo Jiang, Xisheng Xu, Yuliang Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11610551.txt.

Description

Ziqi Zhao, Kun Xu, Yizhuo Jiang, Xisheng Xu, and Yuliang Liu mapped the literature on artificial intelligence in research on immune checkpoint inhibitors, in a study published in 2024. These inhibitors have transformed cancer care, and AI is now woven through their study, yet no full map of that joint field existed.

The team analyzed seven hundred seventy-four papers from 2018 to mid-2024 with mapping software. Output rose steadily, led by China and the United States, with one Chinese university and a few named researchers most prominent. Hot topics included a leading drug, lung cancer uses, and gene expression work. The most valued journal by citations was a top medical title, while an immunology journal carried the most papers. The authors call for wider global teamwork to solve the field's remaining problems.

Catalog record

CREATORZiqi Zhao, Kun Xu, Yizhuo Jiang, Xisheng Xu, Yuliang Liu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11610551

Browse the full library · About the Tower of Babel